Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about DayOneBiopharmaceuticalsInc-2021-05-26
$184.0 Million
Image
Day One Biopharmaceuticals, Inc.
Initial Public Offering
Active Bookrunner
Read more
about CVRxInc-2021-06-29
$144.9 Million
Image
CVRx, Inc.
Initial Public Offering
Active Bookrunner
Read more
about CenturyTherapeuticsInc-2021-06-17
$242.0 Million
Image
Century Therapeutics, Inc.
Initial Public Offering
Active Bookrunner
Read more
about BiomeaFusion-2021-04-15
$176.0 Million
Image
Biomea Fusion
Initial Public Offering
Active Bookrunner
Read more
about CytekBiosciencesInc-2021-07-22
$284.7 Million
Image
Cytek Biosciences, Inc.
Initial Public Offering
Active Bookrunner
Read more
about DesignTherapeutics-2021-03-25
$276.0 Million
Image
Design Therapeutics
Initial Public Offering
Active Bookrunner
Read more
about ReneoPharmaceuticals-2021-04-08
$93.7 Million
Image
Reneo Pharmaceuticals
Initial Public Offering
Active Bookrunner
Read more
about TalisBiomedical-2021-02-11
$253.9 Million
Image
Talis Biomedical
Initial Public Offering
Active Bookrunner
Read more
about SenseiBiotherapeuticsInc-2021-02-03
$152.5 Million
Image
Sensei Biotherapeutics, Inc.
Initial Public Offering
Active Bookrunner
Read more
about AkoyaBiosciencesInc-2021-04-15
$151.3 Million
Image
Akoya Biosciences, Inc.
Initial Public Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 18
Next page
››
Subscribe to Active Bookrunner